Appointment reflects Glauconix Biosciences' readiness to expand their commercial footprint and business verticals in the field of ophthalmology and beyond

Study confirms intraocular pressure-lowering effects of cannabinoid-based therapeutic, proving promising novel treatment for glaucoma